Your browser doesn't support javascript.
loading
The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study.
Cumplido-Mayoral, Irene; Brugulat-Serrat, Anna; Sánchez-Benavides, Gonzalo; González-Escalante, Armand; Anastasi, Federica; Milà-Alomà, Marta; López-Martos, David; Akinci, Muge; Falcón, Carles; Shekari, Mahnaz; Cacciaglia, Raffaele; Arenaza-Urquijo, Eider M; Minguillón, Carolina; Fauria, Karine; Molinuevo, José Luis; Suárez-Calvet, Marc; Grau-Rivera, Oriol; Vilaplana, Verónica; Gispert, Juan Domingo.
Afiliación
  • Cumplido-Mayoral I; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Biomedicine, Universitat Pompeu Fabra, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain.
  • Brugulat-Serrat A; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • Sánchez-Benavides G; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • González-Escalante A; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Biomedicine, Universitat Pompeu Fabra, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain.
  • Anastasi F; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelon
  • Milà-Alomà M; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Department of Veterans Affairs Medical Center, Northern California Institute for Research and Education, San Francisco, CA, USA; Department of Radiology, University of California, San Francisco, CA, USA.
  • López-Martos D; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain.
  • Akinci M; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Biomedicine, Universitat Pompeu Fabra, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; Barcelona Institute of Global
  • Falcón C; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
  • Shekari M; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Biomedicine, Universitat Pompeu Fabra, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain.
  • Cacciaglia R; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • Arenaza-Urquijo EM; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
  • Minguillón C; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • Fauria K; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • Molinuevo JL; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; H Lundbeck, Copenhagen, Denmark.
  • Suárez-Calvet M; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • Grau-Rivera O; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Fragilidad y Envejecimiento Saludable, Instituto de Salud Carlos III, Madrid, Sp
  • Vilaplana V; Department of Signal Theory and Communications, Universitat Politècnica de Catalunya, Barcelona, Spain.
  • Gispert JD; Barcelonaßeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain; Neuroimagen de Enfermedades Neurodegenerativas y Envejecimiento Saludable, Hospital del Mar Research Institute, Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicin
Lancet Healthy Longev ; 5(4): e276-e286, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38555920
ABSTRACT

BACKGROUND:

Neuroimaging-based brain-age delta has been shown to be a mediator linking cardiovascular risk factors to cognitive function. We aimed to assess the mediating role of brain-age delta in the association between modifiable risk factors of dementia and longitudinal cognitive decline in middle-aged and older individuals who are asymptomatic, stratified by Alzheimer's disease pathology. We also explored whether the mediation effect is specific to cognitive domain.

METHODS:

In this cohort study, we included participants from the ALFA+ cohort aged between 45 years and 65 years who were cognitively unimpaired and who had available structural MRI, cerebrospinal fluid ß-amyloid (Aß)42 and Aß40 measurements obtained within 1 year of each other, modifiable risk factors assessment, and cognitive evaluation over 3 years. Participants were recruited from the Barcelonaßeta Brain Research Center (Barcelona, Spain). Included individuals underwent a first assessment between Oct 25, 2016, and Jan 28, 2020, and a follow-up cognitive assessment 3·28 (SD 0·27) years later. We computed brain-age delta and composites of different cognitive function domains (preclinical Alzheimer's cognitive composite [PACC], attention, executive function, episodic memory, visual processing, and language). We used partial least squares path modelling to explore mediation effects in the associations between modifiable risk factors (including cardiovascular, mental health, mood, metabolic or endocrine history, and alcohol use) and changes in cognitive composites. To assess the role of Alzheimer's disease pathology, we computed separate models for Aß-negative and Aß-positive individuals.

FINDINGS:

Of the 419 participants enrolled in ALFA+, 302 met our inclusion criteria, of which 108 participants were classified as Aß-positive and 194 as Aß-negative. In Aß-positive individuals, brain-age delta partially mediated (percent mediation proportion 15·73% [95% CI 14·22-16·66]) the association between modifiable risk factors and decline in overall cognition (across cognitive domains). Brain-age delta fully mediated (mediation proportion 28·03% [26·25-29·21]) the effect of modifiable risk factors on the PACC, wherein increased values for risk factors correlated with an older brain-age delta, and, consequently, an older brain-age delta was linked to greater PACC decline. This effect appears to be primarily driven by memory decline. Mediation was not significant in Aß-negative individuals (3·52% [0·072-4·17]) on PACC, although path coefficients were not significantly different from those in the Aß-positive group.

INTERPRETATION:

Our findings suggest that brain-age delta captures the association between modifiable risk factors and longitudinal cognitive decline in middle-aged and older people. In asymptomatic middle-aged and older individuals who are Aß-positive, the pathology might be the strongest driver of cognitive decline, whereas the effect of risk factors is smaller. Our results highlight the potential of brain-age delta as an objective outcome measure for preventive lifestyle interventions targeting cognitive decline.

FUNDING:

La Caixa Foundation, the TriBEKa Imaging Platform, and the Universities and Research Secretariat of the Catalan Government. TRANSLATION For the Spanish translation of the abstract see Supplementary Materials section.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Aged / Humans / Middle aged Idioma: En Revista: Lancet Healthy Longev Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Límite: Aged / Humans / Middle aged Idioma: En Revista: Lancet Healthy Longev Año: 2024 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido